Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Aug 12, 2014 · 10-Q · 43 days after period end · 0001193125-14-306610
| Metric | Q2 2014 | Q2 2013 |
|---|---|---|
| Revenue | $33.00K | — |
| Net Income | -$7.40M | -$4.89M |
| EPS Diluted | -$0.44 | -$7.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 12, 2014 · 43 d after period end
